RENEW
DEAD

Serial Number

88425671

Owner

Aphria Inc.

Attorney

Courtney Thompson

Filing Date

May 10, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RENEW Trademark

Serial Number: 88425671

RENEW is a trademark filed by Aphria Inc. on May 10, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 34 (Smokers Articles). The application is currently no longer active.

Owner Contact Info

Aphria Inc. (125 trademarks)

265 Talbot Street West
Leamington, Ontario N8H4H3 , CA

Entity Type: 99

Trademark Details

Filing Date

May 10, 2019

Registration Date

Not Registered

Goods & Services

Oils derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food; hemp related products, namely, oils for use as comestibles, namely, edible oil for cooking, edible oils and fats, processed oils for food solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; food products containing hemp, resins, and oils, namely, butter; all of the foregoing containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD

medicated liquid soaps; disinfectant and anti-bacterial liquid soaps; medicated skin care preparations; Hemp related products, namely, medicinal oils solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; tinctures, tablets and capsules for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; medicated oils, and concentrated pastes for the treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders, and anxiety; tinctures, tablets and capsules each containing resins and oils derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for treatment of chronic pain, joint pain, seizures, insomnia, nausea, dietary disorders and anxiety; nutraceuticals for medicinal purposes for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; nutraceuticals for medicinal purposes containing derivatives of hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD, namely, resins and oils for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; medicated topical skin creams, medicated bar and liquid soaps; medicated bath additives, namely, bath herbs, bath oils, bath salts; medicated body creams, medicated body oils, medicated face and body lotions, medicated face and body milk, medicated face lotion, and medicated skin care preparations each of the foregoing containing derivatives of hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid; personal sexual lubricants; transdermal patches containing derivatives of hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; oral sprays for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; hemp related products, namely, oils for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; oils derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD for medicinal use for the relief of pain, for relaxation, for reducing stress and fatigue, for mood enhancement, for maintaining general health and well-being, for relieving anxiety, for relieving depression, as a sleep aid and for management of opioid addiction and relief of epilepsy; all of the foregoing containing ingredients solely derived from hemp with a delta- 9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD

Smokers' articles, namely, grinders for use with hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; smokers' articles, namely, smoking pipes, oral vaporizers for smokers; all of the foregoing containing ingredients solely derived from hemp or exclusively for use with goods containing ingredients solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD; smokers' articles, namely, pouches for use with hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD, lighters for smokers

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Feb 14, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 14, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 28, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 28, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 28, 2024 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 14, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Feb 20, 2024 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Feb 5, 2024 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Jan 26, 2024 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 1, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 1, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 1, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 1, 2022 CNRT
ASSIGNED TO EXAMINER
Apr 18, 2022 DOCK
ASSIGNED TO EXAMINER
Mar 1, 2022 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 14, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 14, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 25, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 25, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 25, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 25, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 25, 2021 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 13, 2021 GNRN
NON-FINAL ACTION E-MAILED
Aug 13, 2021 GNRT
NON-FINAL ACTION WRITTEN
Aug 13, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2021 CRFA
ASSIGNED TO LIE
Jun 17, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 2, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 27, 2020 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 27, 2020 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 27, 2020 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 27, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 27, 2020 GNSL
SUSPENSION LETTER WRITTEN
Apr 27, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 22, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 21, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 21, 2019 GNRN
NON-FINAL ACTION E-MAILED
Oct 21, 2019 GNRT
NON-FINAL ACTION WRITTEN
Oct 21, 2019 CNRT
ASSIGNED TO EXAMINER
Oct 15, 2019 DOCK
LETTER OF PROTEST EVIDENCE FORWARDED
Jul 29, 2019 LOPT
ASSIGNED TO EXAMINER
May 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2019 NWOS
NEW APPLICATION ENTERED
May 14, 2019 NWAP